retatrutide clinical trial parkinson Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP, Retatrutide produces up to 30.3%
Description
Considering probiotics
Alexandra Sowa discusses the surge in GLP-1 use, concerns over prescriptions without in-person visits and how ChatGPT health may help patients get faster treatment.
What is the difference between semaglutide and GLP-1
GLP-1 has proven its mettle as a well-tolerated, highly effective and sustainable weight loss injection, but many still misunderstand how it works.
Listen here on Spotify (also on all the other platforms):
Accelerated skin aging is a side effect of GLP-1 medications, but experts say there are products that can help
